Exhibit 15: 10-Year Net Survival Rate of Breast and Prostate Cancer Patients Improved cancer survival rates reflect significant gains in science and technology. % 100 - 84 75 72 i = is 60 62 a | 48 40 34 | ae 1971-1972 1980-1981 1990-1991 2000-2001 2005-2006 2010-2011 1971-1972 1980-1981 1990-1991 2000-2001 2005-2006 2010-2011 Breast Cancer veiod ot Diagnosis Prostate Cancer Data as of November 2014. Note: Based on cancer statistics for the UK. Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model. Source: Investment Strategy Group, Cancer Research UK. We conclude that there is undoubtedly prognostications of Hansen in the late 1930s and some degree of mismeasurement. We know that Krugman in the early 1990s. Our clients will be information and communication technology has inundated with conflicting views from headlines evolved significantly and innovation is occurring in the media and books with captivating titles. at a rapid pace. We know that the BEA reviews Separating fact from fiction remains challenging. its statistical methodologies every five years Recently, an article in the Wall Street Journal and revises them as needed, recognizing that highlighted “dwindling gains in science, technology measurement methodologies have to evolve with and medicine.”*° The article suggested that the evolution of the US economy. We also know improvements in breast cancer mortality have that we as consumers carry incredibly powerful slowed since 1985. Exhibit 15 shows the 10-year digital equipment in the palms of our hands and net survival rate for breast cancer and prostate pay less for it than we paid for equipment with cancer since 1971. Maybe it is only a matter of lesser functionalities not so long ago. Common perspective, but, to us, a 78% 10-year survival rate sense supplemented by extensive research by the for breast cancer and an 84% 10-year survival experts on productivity and mismeasurement rate for prostate cancer repre